Johnson & Johnson (JNJ) has agreed to buy Momenta Pharma (MNTA), a biotech focused on discovering and developing novel biologic therapeutics for rare …
Biotechs on a tear have been a theme in 2020. Most have taken off on the hope of solving the COVID-19 vaccine or …
DryShips Inc. (NASDAQ:DRYS) stock is sinking by 25% in Tuesday’s trading session, after the shipping company announced that it has entered into agreements to …
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) shares are tumbling 4% today, with sales for its generic copaxone (glatopa), an injection designed to treat patients with …
Maxim Group analyst Jason Kolbert reiterated a Buy rating on Momenta Pharmaceuticals (NASDAQ:MNTA) with a price target of $17.00, as the company reported 3Q14 with …
In a research report issued Monday, analyst Jason Kolbert of Maxim Group reiterated a Buy rating on Momenta Pharmaceuticals (NASDAQ:MNTA) with a $17 price target, following the …
In a research report issued today, Maxim Group analyst Jason Kolbert assigned a Buy rating on Momenta Pharmaceuticals (NASDAQ:MNTA) with a $17 price …
In a research note released today, Maxim Group analyst Jason Kolbert maintained a Buy rating on Momenta Pharmaceuticals (NASDAQ:MNTA) with a $17 price …
Maxim Group analyst Jason Kolbert today issued a note in which he reiterated a Buy rating on Momenta Pharma (MNTA) with a $17 price target. Momenta continues …
